Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beads
Tóm tắt
Từ khóa
Tài liệu tham khảo
de Baere, 1995, Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study, Radiology, 194, 165, 10.1148/radiology.194.1.7997545
Gupta, 2005, Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival, Cancer, 104, 1590, 10.1002/cncr.21389
Marrache, 2007, Arterial phase enhancement and body mass index are predictors of response to chemoembolization for liver metastases of endocrine tumours, Br J Cancer, 96, 49, 10.1038/sj.bjc.6603526
Johnson, 1991, Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol, J Hepatol, 13, 120, 10.1016/0168-8278(91)90873-A
Lewis, 2006, Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization, J Vasc Interv Radiol, 17, 1335, 10.1097/01.RVI.0000228416.21560.7F
Hong, 2006, New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer, Clin Cancer Res, 12, 2563, 10.1158/1078-0432.CCR-05-2225
Varela, 2007, Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics, J Hepatol, 46, 474, 10.1016/j.jhep.2006.10.020
Nicolini, 2010, Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma, J Vasc Interv Radiol, 21, 327, 10.1016/j.jvir.2009.10.038
Lammer, 2010, Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study, Cardiovasc Intervent Radiol, 33, 41, 10.1007/s00270-009-9711-7
Cho, 1983, Experimental hepatic artery embolization with Gelfoam powder. Microfil perfusion study of the rabbit liver, Invest Radiol, 18, 189, 10.1097/00004424-198303000-00017
Chung, 2010, Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolization for hepatic malignancy: interpretation of imaging findings, Br J Radiol, 83, 71, 10.1259/bjr/82377365
Chung, 1996, Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization, Radiology, 198, 33, 10.1148/radiology.198.1.8539401
Doppman, 1979, Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion, Radiology, 130, 1, 10.1148/130.1.1
Kobayashi, 1993, Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus, Am J Gastroenterol, 88, 1410
Makuuchi, 1985, Bile duct necrosis: complication of transcatheter hepatic arterial embolization, Radiology, 156, 331, 10.1148/radiology.156.2.2989972
Yu, 2002, Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy, Cardiovasc Intervent Radiol, 25, 270, 10.1007/s00270-001-0049-z
Yu, 2001, Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations, Radiology, 221, 429, 10.1148/radiol.2212010339
Malagari, 2011, Safety profile of sequential transcatheter chemoembolization with DC Bead (TM): results of 237 hepatocellular carcinoma (HCC) patients, Cardiovasc Intervent Radiol, 34, 774, 10.1007/s00270-010-0044-3
Poon, 2007, A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead, Clin Gastroenterol Hepatol, 5, 1100, 10.1016/j.cgh.2007.04.021
Reyes, 2009, Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States, Cancer J, 15, 526, 10.1097/PPO.0b013e3181c5214b
Cui, 2009, Fractional polynomials and model selection in generalized estimating equations analysis, with an application to a longitudinal epidemiologic study in Australia, Am J Epidemiol, 169, 113, 10.1093/aje/kwn292
Pan, 2001, Akaike’s information criterion in generalized estimating equations, Biometrics, 57, 120, 10.1111/j.0006-341X.2001.00120.x
de Baere, 2008, Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results, J Vasc Interv Radiol, 19, 855, 10.1016/j.jvir.2008.01.030
Gaur, 2011, Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver, Cardiovasc Intervent Radiol, 34, 566, 10.1007/s00270-011-0122-1
Kim, 2001, Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma, J Clin Gastroenterol, 32, 423, 10.1097/00004836-200105000-00013
Namur, 2010, Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model, J Vasc Interv Radiol, 21, 259, 10.1016/j.jvir.2009.10.026
Botet, 1985, Cholangitis complicating intraarterial chemotherapy in liver metastasis, Radiology, 156, 335, 10.1148/radiology.156.2.3160063
Loth, 1986, Treatment methods for extravasations of chemotherapeutic agents: a comparative study, J Hand Surg Am, 11, 388, 10.1016/S0363-5023(86)80147-2
Shea, 1986, Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic–histologic correlation, AJR Am J Roentgenol, 146, 717, 10.2214/ajr.146.4.717
Kobayashi, 1994, Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey, Hum Pathol, 25, 940, 10.1016/0046-8177(94)90016-7
Demachi, 1995, The protective effect of portoarterial shunts after experimental hepatic artery embolization in rats with liver cirrhosis, Cardiovasc Intervent Radiol, 18, 97, 10.1007/BF02807230